Patents by Inventor Marc A. Pfeffer

Marc A. Pfeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of angiotensin II receptor blocker and beta-blocker for secondary prevention of myocardial infarction
    Publication number: 20060014839
    Abstract: The invention relates to a method of treating cardiovascular disease in patients following myocardial infarction comprising administering an effective amount of an ARB, especially valsartan, in combination within an effective amount of a beta-blocker to such patients.
    Type: Application
    Filed: May 16, 2003
    Publication date: January 19, 2006
    Inventors: Robert Califf, Malcolm MacNab, John MacMurray, Marc Pfeffer
  • Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
    Patent number: 5977160
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of an angiotensin converting enzyme inhibitor. The angiotensin converting enzyme inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred angiotensin converting enzyme inhibitor is captopril.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: November 2, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald
  • Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
    Patent number: 5972990
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: October 26, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald
  • Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
    Patent number: 5952305
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 14, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald